HOUSTON, TX--(Marketwired - Nov 17, 2014) - COR Medical Technologies (COR) announced today the appointment of Richard N. Agee as its President and Chief Financial Officer. In his new position, Richard will assist company founder and CEO Dr. Vince Friedewald in the launch of CORcare™, which is a comprehensive instant outcome support system for rapid and accurate diagnosis, treatment, and follow-up management of patients with acute and chronic, common and rare diseases involving the cardiovascular system.

"Richard's extensive financial and business services experience, coupled with his background in healthcare, investment banking, and technology make him a strong asset to the company," said Dr. Vince Friedewald. "I look forward to working with Richard as we introduce CORcare to healthcare professionals around the world." 

Prior to joining COR Medical Technologies, Richard was a Principal at Stoneworth Financial, a Houston-based investment banking firm, where he provided buy-side and sell-side advice to clients, and advised and actively assisted start-up ventures. Richard was also Chief Financial Officer and Executive Vice President at AR Group, where he oversaw the human resources, legal, and benefits administration departments and was instrumental, along with the other members of the team, in positioning the company for sale. In addition, he has managed engagements for some of the largest hospitals and financial institutions at a reputable regional public accounting firm. Richard graduated from the University of Oklahoma with a degree in accounting and finance. He resides in Austin, Texas with his family.

"I am excited to join the company and assist Dr. Friedewald in showcasing the benefits of CORcare to physicians, EMTs, nurses, physician assistants, hospitals, and physician groups," said Richard Agee. "I believe CORcare has the potential to dramatically improve outcomes for patients resulting in greater longevity and quality of life."

COR Medical Technologies recently introduced CORcare, which helps healthcare professionals consider all possible conditions associated with any single or combination of clinical features for rapid assistance in differential diagnosis and narrowing down to the final diagnosis. CORcare is the first system to embed ACCF/AHA Guidelines specific to data points within each condition, providing instant graded opinions of leading authorities. This feature fully supports and uses the "Guideline Directed Medical Therapy (GDMT)" initiative of the AHA and ACC. COR Medical Technologies was developed by esteemed cardiologist, Vincent Friedewald, M.D., F.A.C.C. 

About COR Medical Technologies
COR Medical Technologies offers CORcare™, the world's most comprehensive instant outcome support system for heart disease. It was developed by healthcare practitioners and is designed for use at the time of care to improve diagnostic accuracy and treatment practices to optimize patient outcomes. The outcome support system is available on a variety of platforms including mobile devices. For more information please visit www.cormedtec.com. Also follow COR Medical Technologies on LinkedIn https://www.linkedin.com/company/cor-medical-technologies and Twitter at www.twitter.com/cormedtec.  

Contact Information:

Media Contacts:
Joshua Taustein
Dresner Corporate Services

Doug Dusik
Dresner Corporate Services